Early Phase 1 Chronic Kidney Disease Trial, Recruiting NCT06430684 Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Early Phase 1 Chronic Kidney Disease Trial, Recruiting

NCT06430684
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have stage 3 or 4 chronic kidney disease (CKD), with kidney function test results falling within a specific range (confirm with trial site for exact values)

Who may not be able to join:

  • People who have heart disease
  • People who have diabetes
  • People who are pregnant
  • People who have received a solid organ transplant (such as a kidney, liver, or heart transplant)
  • People who have previously undergone chemotherapy or a stem cell transplant
  • People with moderate to severe persistent asthma
  • People who have liver disease
  • People with class 2 or higher obesity (confirm with trial site for exact definition)
  • People whose cognitive impairment would make it difficult to follow the study procedures
  • People who have a urinary tract blockage or who need to use a urinary catheter regularly
  • People whose resting blood pressure is below a certain low level (confirm with trial site)
  • People who experience a significant drop in blood pressure when standing up
  • People who are currently taking a type of diabetes/kidney medication known as an SGLT2 inhibitor
  • People whose blood pressure medications are expected to need adjustment within the next 3 months
  • People who are currently taking medications that suppress the immune system
  • People whose kidney specialist has not given approval for them to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Phone: 312-227-6160

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Registry
ClinicalTrials.gov
Start date
23 August 2024
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percentage of participants who complete all study procedures

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov